Clinical Anti-Inflammatory and Anti-Allergy Drugs
Published by Bentham Science Publishers
ISSN : 2212-7038 eISSN : 2212-7046
Abbreviation : Clin. Anti-inflamm. Anti-allergy Drug
Aims & Scope
Clinical Anti-Inflammatory & Anti-Allergy Drugs publishes original research, expert reviews, drug clinical trials and thematic issues in all core areas of translational and clinical anti-inflammatory & anti-allergy drug research.
The journal publishes pre-clinical and clinical studies on the development of new anti-inflammatory & anti-allergy agents.
Clinical studies of new reported anti-inflammatory & anti-allergy drugs include Phase 1 – IV clinical trial studies, their designs, research methodologies, and analyses.
The journal is essential reading to clinicians, toxicologists, medicinal chemists, and to pharmacologists.
View Aims & ScopeAbstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Quilizumab is an Afucosylated Humanized Anti-M1 Prime Therapeutic Antibody
Citation: 20
Authors: Hans, Yuwen, Zhonghua, Martha, Y., Mercedesz, Shan, Lawren
-
Systemic Application of Anti-inflammatory Agents in Periodontal Treatment
Citation: 13
Authors: Kevimy, David-Nicolas, Henri, Jean-Luc, Olivier
-
Synthesis and Pharmacological Studies of Novel 3-Substituted Indole Derivatives as Potential Anti-Inflammatory and Analgesic Agents
Citation: 5
Authors: Mayura, Ashok, Tukaram
-
Plant-based Anti-inflammatory Agents: Progress From Africa and China
Citation: 5
Authors: James, Xiao-Dan, Jun, Peng, Chun, Wei
-
Hydrogen Sulfide: A New Tool to Design and Develop Drugs
Citation: 4
Authors: Nethaji, Abel, Alireza, Jack, Madhav
-
Commercially Available, FDA-approved Epigenetic Modifiers As Therapeutic Agents in Bacterial Infection
Citation: 4
Authors: Pádraic, Georgia, Joseph
-
Chemical Inhibition of Matrix Metalloproteinases for Periodontal Treatment
Citation: 2
Authors: Nurdan, Ceren
-
Randomized, Placebo Controlled Study of the Effects of Etoricoxib on Markers of Inflammation, Pain and Muscle Force After Eccentric Exercise
Citation: 1
Authors: Matthias, Egbert, Ilka, Steffen